Hubei Beike And Stada Arzneimittel Collaborate On Children's Drug In China
This article was originally published in PharmAsia News
Executive Summary
German-based Stada Arzneimittel, Europe's largest generic drug producer, and Hubei Beike Medicine Company have reached a strategic agreement to collaborate in all aspects of children's drugs in China including research and development, production and marketing. Under the agreement, Beike will be fully responsible for promoting and selling Stada's antipyretic drugs and paracetamol drops for children locally. With its professional focus on children's drug development, Beike's distribution network enjoys strong local market penetration, which extends to prefecture-level cities. (Click here for more - Chinese Language)